About Piraeus Medical
Piraeus Medical is a private company based in Rochester, Minnesota. It has reported $21,053,309 raised in ten offerings on Form D since June 2022. Its chief executive is Jared Hutar.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 31, 2026 | Apr 2, 2026amended Oct 7, 2026 | $10,525,100of $12.0M target | 25 | $421K | Equity, Shares of Issuer Preferred Stock and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.Rule 506(b) | Form D/A ↗1 earlier filing |
| Oct 31, 2025 | Nov 5, 2025 | $662,600of $2.2M target | 4 | $165K | Options, The "Option, Warrant or Other Right" is a Simple Agreement for Future Equity (SAFE), the capital stock of the Issuer into which the SAFE may convert (SAFE Shares) and the capital stock of the Issuer into which the SAFE Shares may convert.Rule 506(b) | Form D ↗ |
| Sep 18, 2025 | Sep 22, 2025 | $300,000fully sold | 1 | $300K | Options, The "Option, Warrant or Other Right" is a Simple Agreement for Future Equity (SAFE), the capital stock of the Issuer into which the SAFE may convert (SAFE Shares) and the capital stock of the Issuer into which the SAFE Shares may convert.Rule 506(b) | Form D ↗ |
| Feb 7, 2025 | Feb 19, 2025 | $2,000,001fully sold | 65 | $30,769 | Equity, Shares of Preferred Stock of Issuer and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.Rule 506(b) | Form D ↗ |
| Jul 19, 2024 | Jul 23, 2024 | $6,000,000fully sold | 79 | $75,949 | Equity, Shares of Preferred Stock of Issuer and the shares of capital stock of Issuer into which such shares of Preferred Stock may convert.Rule 506(b) | Form D ↗ |
| Aug 1, 2023 | Aug 9, 2023 | $3,108fully sold | 2 | $1,554 | EquityRule 506(b) | Form D ↗ |
| Jun 22, 2023 | Jul 3, 2023amended Apr 4, 2024 | $450,000of $3.5M target | 5 | $90,000 | Options, The "Option, Warrant or Other Right" is a Simple Agreement for Future Equity (SAFE), the capital stock of the Issuer into which the SAFE may convert (SAFE Shares) and the capital stock of the Issuer into which the SAFE Shares may convert.Rule 506(b) | Form D/A ↗1 earlier filing |
| Dec 8, 2022 | Dec 9, 2022 | $150,000of $3.5M target | 2 | $75,000 | Options, The "Option, Warrant or Other Right" is a Simple Agreement for Future Equity (SAFE), the capital stock of the Issuer into which the SAFE may convert (SAFE Shares) and the capital stock of the Issuer into which the SAFE Shares may convert.Rule 506(b) | Form D ↗ |
| May 17, 2022 | Jun 16, 2022 | $900,000target not set | 13 | $69,231 | Options, The "Option, Warrant or Other Right" is a Simple Agreement for Future Equity (SAFE), the capital stock of the Issuer into which the SAFE may convert (SAFE Shares) and the capital stock of the Issuer into which the SAFE Shares may convert.Rule 506(b) | Form D ↗ |
| Jun 2, 2022 | Jun 9, 2022 | $62,500fully sold | 2 | $31,250 | Equity, Shares of preferred stock of the Issuer (Preferred Shares), and the shares of capital stock of the Issuer into which the Preferred Shares may convert.Rule 506(b) | Form D ↗ |
| Total, ten offerings | $21,053,309 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Piraeus Medical's Form D filed Oct 7, 2026.
JH
KK
KK
Keith Kallmes
Director
Also a director at Momease Solutions and a chief executive officer and director at Nested Knowledge.
MA
Martin Akhavan
Director
RE